“…Doxorubicin (DOX) and paclitaxel are two of the most commonly used chemotherapeutic drugs [ 239 ]. Taking their adverse effects into consideration, studies have proposed alternative forms of drug delivery, such as liposome formulations [ 239 ], solid lipid NPs [ 240 ], mucoadhesive alginate pastes with embedded liposomes [ 241 ], methotrexate-loaded stimuli responsive silica-based NPs [ 242 ], polymers [ 243 ], PEGylated NPs [ 244 , 245 ], mesoporous silica NPs-polymerpolyethylenimine [ 246 ], multifunctional targeted polymeric NPs [ 247 ], and a multifunctional Au nanoplatform [ 248 ]. In comparison to the free drugs, these new systems showed a higher percentage of apoptotic cells [ 239 , 247 ], fewer hematological changes [ 242 ], significant therapeutic efficacy [ 243 , 248 ], significant inhibitory effects on tumor growth [ 245 ], lower cytotoxicity and systemic toxicity, and higher tumor accumulation of DOX [ 244 ].…”